Aprepitant 80 mg Oral Capsule: Clinical Trials

1 trial of Aprepitant 80 mg Oral Capsule, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Aprepitant 80 mg Oral Capsule: new trials by email Literature Review of Aprepitant 80 mg Oral Capsule trials Research Report on Aprepitant 80 mg Oral Capsule

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Aprepitant 80 mg Oral Capsule, scopolamine transdermal, Total intravenous anesthesia - Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Phase 4CompletedStony Brook University832017-08-282024-02-14

Conditions studied

Vomiting (1)

Sponsors

Stony Brook University (1)

Countries

United States (1)

Top investigators

Konstantinos Spaniolas, MD (1)

Results publications

PMID 33528788